Crescent Biopharma to Present at September Investor Conferences
Provided By GlobeNewswire
Last update: Aug 28, 2025
WALTHAM, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that management is scheduled to present at the following investor conferences in September:
Read more at globenewswire.com
